Showing results (111-120 of 196) with videos related to
Sort By:
Pageof 20
Mayo Clinic Proceedings|June 1, 1991
Platelet von Willebrand factorH R Gralnick, S B Williams, L P McKeown, et al.Journal of Veterinary Internal Medicine|October 3, 2014
Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphomaM A Morges, J H Burton, C F Saba, et al.Methodsx|December 29, 2025
SatTCR: a pipeline for performing saturation analysis of the T cell receptor repertoire and a case study of a healthy canineRene Welch Schwartz, Cindy L Zuleger, Michael A Newton, et al.Journal of Toxicology and Environmental Health. Part A|January 10, 2022
Implications of peroxisome proliferator-activated receptor gamma (PPARY) with the intersection of organophosphate flame retardants and diet-induced obesity in adult miceGwyndolin M Vail, Sabrina N Walley, Ali Yasrebi, et al.Journal of the American Animal Hospital Association|January 6, 2009
Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogsBrenda Phillips, Barbara E Powers, William S Dernell, et al.British Journal of Haematology|March 1, 1992
Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogenH R Gralnick, S B Williams, L McKeown, et al.Quintessence International (Berlin, Germany : 1985)|July 15, 2014
Susceptibility of methacrylate-based root canal filling to degradation by bacteria found in endodontic infectionsJenny D Whatley, Kenneth J Spolnik, Mychel M Vail, et al.Journal of Toxicology and Environmental Health. Part A|January 20, 2022
Implications of estrogen receptor alpha (ERa) with the intersection of organophosphate flame retardants and diet-induced obesity in adult miceGwyndolin M Vail, Sabrina N Walley, Ali Yasrebi, et al.Veterinary and Comparative Oncology|May 16, 2013
Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell linesJ A Lawrence, M K Huelsmeyer, D H Thamm, et al.Veterinary and Comparative Oncology|May 6, 2016
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding studyM A Pellin, R M Wouda, K Robinson, et al.Pageof 20